NCT02924844已完成不适用
Impact of the Implementation of a Clinical Pharmacy Bundle on Intensive Care Unit Patient Outcomes and Cost Expenditures
Centre Hospitalier Universitaire de Nīmes1 个研究点 分布在 1 个国家目标入组 2,787 人开始时间: 2013年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 2,787
- 试验地点
- 1
- 主要终点
- Length of hospital stay
研究概览
简要总结
The aim of this before-after study was to assess the impact of a clinical pharmacy bundle of care activities on patient outcomes (length of hospital stay as a primary endpoint) and cost expenditure in two French ICUs.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Intensive Care Unit patients on weekdays
排除标准
- 未提供
研究组 & 干预措施
Observation period before presence of clinical pharmacist
The group of patients was observed between Janary 2013 and December 2013
Period with presence of clinical pharmacist
The group of patients was observed between January 2014 and June 2015.
结局指标
主要结局
Length of hospital stay
时间窗: expected average of 20 days
次要结局
- Intensive Care Unit length of stay(Expected maximum of 10 days)
- Mechanical ventilation duration(Expected maximum of 10 days)
- Intensive care unit mortality rate(Expected maximum of 10 days)
- Hospital mortality rate(End of hospital stay (expected average of 20 days))
- Patient cost expenditure(End of hospital stay (expected average of 20 days))
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
Impact of Clinical Pharmacy Services on Medication Cost and Hospitalization Rates in Hemodialysis PatientsEnd Stage Renal DiseaseNCT05952388University of New Mexico
已完成
不适用
Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary CareDepressionNCT00794196Fundació Sant Joan de Déu179
已完成
不适用
Clinical Pharmacists' Intervention on Pain Management in Cancer PatientsCancer PainCancerNCT05021393Monash University Malaysia92
已完成
不适用
:Effects of Pharmaceutical Care in Stroke PatientsStrokeNCT06129318Marmara University260
终止
1 期
Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hrHealthyNCT00648414Mylan Pharmaceuticals Inc12